Results 211 to 220 of about 61,865 (283)

Real‐World Safety Profile of Spesolimab in Generalized Pustular Psoriasis: Insights From Japan as Part of a Multinational Expanded Access Program (EAP)

open access: yesThe Journal of Dermatology, Volume 53, Issue 2, Page 351-356, February 2026.
ABSTRACT Generalized pustular psoriasis (GPP) is a heterogeneous, systemic neutrophilic inflammatory disease, characterized by chronic symptoms and recurrent flares, which can be potentially life‐threatening. Spesolimab, an interleukin‐36 receptor antagonist, has been approved to treat GPP flares in many countries including Japan.
Akimichi Morita   +12 more
wiley   +1 more source

The impact of warming on peak‐season ecosystem carbon uptake is influenced by dominant species in warmer sites

open access: yesJournal of Ecology, Volume 114, Issue 2, February 2026.
We report on a 10‐year factorial warming and dominant plant species removal experiment conducted in a high‐ and a low‐elevation montane meadow. We found that dominant plant species can modify the impacts of warming on carbon fluxes, depending on environmental context.
Rose E. Brinkhoff   +11 more
wiley   +1 more source

Impact of Scope of Practice Laws for Certified Registered Nurse Anesthetists on the Utilization of Anesthesia Services

open access: yesHealth Services Research, Volume 61, Issue 1, February 2026.
ABSTRACTObjectiveTo assess the impact of pandemic‐related changes in state scope of practice law (SOPL) for certified registered nurse anesthetists (CRNAs) on the utilization of anesthesia services during the COVID‐19 pandemic, which served as a natural experiment.Study Setting and DesignWe used a difference‐in‐differences approach to compare changes ...
Projesh P. Ghosh   +5 more
wiley   +1 more source

Epidemiology, clinical characteristics, flares and mortality of generalized pustular psoriasis: a nationwide register study in Finland. [PDF]

open access: yesSkin Health Dis
Koivusalo M   +9 more
europepmc   +1 more source

Exploration of Multiple Non‐Invasive Tests for Assessing Response to Treatment in a Semaglutide Phase 2b Trial in Patients with MASH

open access: yesAlimentary Pharmacology &Therapeutics, Volume 63, Issue 3, Page 396-404, February 2026.
This study investigated multiple non‐invasive tests (NIT) in a phase 2b study of patients with MASH and fibrosis treated with semaglutide. Findings revealed that semaglutide significantly improved NIT scores versus placebo from as early as 28 weeks. The results support the use of NITs to assess a treatment response to semaglutide.
Louise Maymann Nitze   +8 more
wiley   +1 more source

Carbon stock, fluxes, and partitioning in Pinus taeda plantations are affected by genetic variation and stand density in Southeast Brazil. [PDF]

open access: yesCarbon Balance Manag
Campoe OC   +8 more
europepmc   +1 more source

Association of the Early Response to an Oral Shape‐Shifting Superabsorbent Hydrogel Capsule With Weight Loss

open access: yesClinical Obesity, Volume 16, Issue 1, February 2026.
ABSTRACT Early response (ER) to treatment is predictive of longer‐term weight loss. In this post hoc analysis, ER to an oral shape‐shifting superabsorbent hydrogel capsule (Epitomee) combined with a lifestyle intervention was compared to placebo combined with a lifestyle intervention.
John M. Jakicic   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy